Tag: COVID-19

Regroup and recharge at OR Manager's leadership conferences

As the nation gradually resumes activities that have been restricted during the COVID-19 pandemic, OR Manager looks forward to hosting two fall conferences. The OR Business Management Conference (ORBMC) takes place in San Diego, September 27-29, and the OR Manager Conference follows in Chicago, October 20-22. There has never been…

Read More

By: Elizabeth Wood
June 22, 2021
Share

Virtual communication triumphs amid pandemic restrictions

Virtual presentations have burgeoned in the wake of COVID-19, and nurse leaders have had to become more adept at both disseminating and receiving information this way. Choosing the right platform, learning the technology, avoiding distractions and system glitches, and using good communication are the primary criteria for success with this…

Read More

By: Elizabeth Wood
June 22, 2021
Share

Decrease uncertainty to combat burnout, boost retention

Provider burnout in the OR has been a problem for years, but the COVID-19 pandemic has brought staff morale to a low point in hospitals across the US. Many OR leaders are facing staffing shortages just as demand for elective surgery is increasing. This is a significant problem for hospitals…

Read More

By: OR Manager
June 22, 2021
Share

Use of COVID-19 symptom incidence in HCWs to estimate hospital admissions in their communities

Editor's Note This study by researchers at Beth Israel Deaconess Medical Center, Boston, finds that healthcare worker (HCW) reported COVID-19 symptoms can be used to estimate hospital demand in the communities where they live. This analysis includes 6,481 HCWs who worked at 1 hospital and lived within a 10-hospital service…

Read More

By: Judy Mathias
June 21, 2021
Share

Incidence of COVID-19 in HCWs after single dose of the Moderna vaccine

Editor's Note This study from the VA Boston Healthcare System finds an association between receipt of Moderna’s mRNA-1273 vaccine and a reduction in COVID-19 infections in healthcare workers (HCWs) beginning 8 days after the first dose. In this analysis of 4,028 HCWs, 3,367 were vaccinated during the study period. Of…

Read More

By: Judy Mathias
June 17, 2021
Share

AI examines gene-expression data to predict COVID-19 outcomes

Editor's Note In this study, researchers from the University of California, San Diego, developed an artificial intelligence (AI) algorithm to identify signature genes that forecast the severity of a viral infection immune response including that of COVID-19. The researchers analyzed more than 45,000 datasets from viral pandemics in humans, mice,…

Read More

By: Judy Mathias
June 17, 2021
Share

Study: HCQ, AZM boost survival of ventilated COVID-19 patients by 200%

Editor's Note This observational study by researchers at Saint Barnabas Medical Center, Livingston, New Jersey, and the Smith Center for Infectious Diseases & Urban Health, East Orange, New Jersey, finds that the use of weight-adjusted hydroxychloroquine (HCQ) and azithromycin (AZM) improved the odds of survival of ventilated COVID-19 patients by…

Read More

By: Judy Mathias
June 15, 2021
Share

Federal judge dismisses Houston Methodist employees’ COVID-19 vaccine mandate lawsuit

Editor's Note A federal judge has dismissed a lawsuit brought by employees of Houston Methodist who challenged the health system’s COVID-19 vaccination mandate, the June 13 New York Times reports. US District Judge Lynn N. Hughes issued a ruling June 12 that upheld the hospital’s policy and noted that the…

Read More

By: Judy Mathias
June 15, 2021
Share

CDC: ED visits for suicide attempts in those aged 12-17 years before, during COVID-19

Editor's Note This study by researchers from the Centers for Disease Control and Prevention (CDC) expands on previous work showing increases in emergency department (ED) visits for suspected suicide attempts early in the pandemic for all ages and suggests that these trends persisted for those aged 12 to 17 years.…

Read More

By: Judy Mathias
June 15, 2021
Share

FDA panel split on COVID-19 vaccines for children

Editor's Note Members of the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee during a June 10 meeting were split on whether COVID-19 vaccines should be granted emergency use authorization (EUA) for children under 12 years of age, the June 11 Regulatory Focus reports. Some members…

Read More

By: Judy Mathias
June 15, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat